Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 06/03

Trade details

Type
Insider sale
Amount
$1,247,007.3
Shares · price
2,310 sh · $539.83 a share
Held after
41,874 sh
Trade date
26/06/02
Filed
26/06/03
Days to filing
1 days

Sold 5.2% of holdings

Share of holding sold
5.2%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 05/03~07/02

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $775.2K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $537.5K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $501.3K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $477.2K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $446.5K

    Filed 10/02